It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Recently published in the Journal of Hematology & Thromboembolic Diseases, the study underscores the potential ‘leukemogenic’ properties of the Bt toxin biopesticides used in almost all GMO foods
Just a few months ago, references to GMO were made by scientists in France who conducted a study that pinpointed Monsanto’s genetically engineered corn, called NK603, as a major cancer-causing agent. Rats developed cancerous tumors the size of ping-pong balls. The study was called into question; however by academics under Monsanto’s reign.
Now, the study states that the biopesticides engineered into crops like corn, soy, sugar cane, etc. carry what is known as Bacillus Thuringiensis (Bt), also called Cry-toxins, which contribute to all sorts of health problems including:
•Blood abnormalities
•Hematological malignancies (blood cancers), i.e. leukemia
•Suppression of bone marrow proliferation
•Abnormal lymphocyte patterns
Originally posted by snarky412
reply to post by intergalactic fire
What's hell is the FDA keeps giving them a free pass.:shk:
Originally posted by Lil Drummerboy
Originally posted by snarky412
reply to post by intergalactic fire
What's hell is the FDA keeps giving them a free pass.:shk:
Maybe cause Monsanto has members on the FDA board
Do some homework and search these evil doers
naturalsociety.com...
Now, the study states that the biopesticides engineered into crops like corn, soy, sugar cane, etc. carry what is known as Bacillus Thuringiensis (Bt), also called Cry-toxins, which contribute to all sorts of health problems including:
•Blood abnormalities
•Hematological malignancies (blood cancers), i.e. leukemia
•Suppression of bone marrow proliferation
•Abnormal lymphocyte patterns
Just like so many other anti-GMO papers pushed by anti-GMO groups, the sample size is far too small. You cannot achieve a statistically significant set of results using only three mice of each sex for each group, especially considering the historical incidences of these blood disorders in the Swiss Albino Mice is not reported.
If the Bt delta endotoxin expressing bacteria did cause various blood disorders, then you would expect to see a relationship between the dose and the response, however we don’t see this in the paper. For example it reports a “U-shaped” dose response curve with high responses at both low and high levels of Cry1Ac after 24 hours. That the mice fed the low levels of Cry1Ab had the highest response, while all levels of Cry1Aa had the same response over a 24 hour period.
Bt spores are widely used in agriculture. But they are not genetically modified to produce toxins. The recombinant proteins are produced by GM plants. Therefore, there is no reason to assay GM Bt spores as alias to GM plants.
The language used in the paper is not clear. The authors claimed to have used spore-crystals. This is not the same as having used purified Cry proteins: to the best of our knowledge, the spore-crystals mentioned here are indeed lyophilized spores for Cry-producing Bt strains, as described in the first paragraph of the Methodology section.
Surprisingly, the authors do not have a fundamental control: a spore not expressing a toxin or expressing an unrelated toxin. The only controls were water (negative) and cyclophosphamide (positive). The lack of this third control prevents any conclusion on the true effect of the toxins on the animals, since all other spore molecular components could also affect the mice in such unusual high concentration as those directly applied to the digestive system in these ill-designed assays.
This article has been withdrawn at the request of the author(s) and/or editor
Food Chem Toxical (a well established journal)
Richard E. Goodman is professor at the Food Allergy Research and Resource Program, University of Nebraska. But he is also a former Monsanto employee, who worked for the company between 1997 and 2004.
Goodman had no documented connection to the journal until February 2013. His fast-tracked appointment, directly onto the upper editorial board raises urgent questions. Does Monsanto now effectively decide which papers on biotechnology are published in FCT? And is this part of an attempt by Monsanto and the life science industry to seize control of science?
Originally posted by thishereguy
so does this mean i can sue monsanto for my luekemia?